Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Novel antisense oligonucleotide safe in preliminary data from phase I advanced cancer study

Nov. 3, 2008

New radiotherapeutic shows promising results in murine and primate melanoma models

Nov. 3, 2008

TRC-105 tolerated, active in ongoing phase I cancer study

Nov. 3, 2008

Recent patents impart new oncolytic drugs

Nov. 3, 2008

Eupatilin induces apoptosis in colon cancer cell line

Nov. 3, 2008

FDA accepts for priority review ImClone and Bristol-Myers' sBLA for Erbitux

Oct. 31, 2008

Telik reports top-line results from Assist-5 trial in ovarian cancer

Oct. 31, 2008

Infinity expands phase II study of IPI-504 in advanced non-small cell lung cancer

Oct. 31, 2008

SuperGen reports on development of JAK2 inhibitor SGI-1252

Oct. 31, 2008

Preclinical data on D-3263 show anticancer potential of TrpM8 agonism

Oct. 31, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...